Asia-Pacific Pelvic Floor Electric Stimulator Market - Industry Trends and Forecast to 2028

TABLE OF CONTENT

TABLE OF CONTENTS 1 INTRODUCTION 34 1.1 OBJECTIVES OF THE STUDY 34 1.2 MARKET DEFINITION 34 1.3 OVERVIEW OF ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET 34 1.4 LIMITATIONS 36 1.5 MARKETS COVERED 36 2 MARKET SEGMENTATION 38 2.1 MARKETS COVERED 38 2.2 GEOGRAPHICAL SCOPE 39 2.3 YEARS CONSIDERED FOR THE STUDY 40 2.4 CURRENCY AND PRICING 40 2.5 DBMR TRIPOD DATA VALIDATION MODEL 41 2.6 MULTIVARIATE MODELLING 44 2.7 PRODUCT TYPE LIFELINE CURVE 44 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45 2.9 DBMR MARKET POSITION GRID 46 2.10 MARKET APPLICATION COVERAGE GRID 47 2.11 VENDOR SHARE ANALYSIS 48 2.12 SECONDARY SOURCES 49 2.13 ASSUMPTIONS 49 3 EXECUTIVE SUMMARY 50 4 PREMIUM INSIGHTS 53 5 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET: REGULATIONS 54 5.1 U.S 54 5.2 EUROPE 55 5.3 CHINA 55 5.4 AUSTRALIA 56 6 MARKET OVERVIEW 57 6.1 DRIVERS 59 6.1.1 RISING GERIATRIC POPULATION 59 6.1.2 INCREASING PREVALENCE OF CHRONIC DISEASES 62 6.1.3 INTRODUCTION OF ADVANCE TECHNOLOGY BASED PELVIC FLOOR ELECTRIC STIMULATOR 64 6.1.4 RISING PER CAPITA INCOME 64 6.2 RESTRAINTS 65 6.2.1 HIGH COST OF PELVIC FLOOR ELECTRIC STIMULATOR 65 6.2.2 LACK OF AWARENESS 66 6.3 OPPORTUNITIES 66 6.3.1 INCREASING HEALTHCARE EXPENDITURE ACROSS THE WORLD 66 6.3.2 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE 68 6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 69 6.4 CHALLENGES 69 6.4.1 LACK OF ACCESSIBILITY 69 6.4.2 STRINGENT REGULATION POLICY 70 7 IMPACT OF COVID-19 ON THE ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET 72 7.1 IMPACT ON PRICE 72 7.2 IMPACT ON DEMAND 72 7.3 IMPACT ON SUPPLY CHAIN 72 7.4 STRATEGIC DECISIONS FOR MANUFACTURERS 73 7.5 CONCLUSION 73 8 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY PRODUCT TYPE 74 8.1 OVERVIEW 75 8.2 MOBILE 78 8.2.1 HAND-HELD 78 8.2.2 TRANSPORTABLE 79 8.3 FIXED 79 8.3.1 TABLE-TOP 80 8.3.2 TROLLEY-FIXED 80 8.4 WEARABLE 80 9 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY DEVICE TYPE 81 9.1 OVERVIEW 82 9.2 NON-IMPLANTABLE ELECTRICAL STIMULATOR DEVICE 85 9.3 IMPLANTABLE ELECTRICAL STIMULATOR DEVICE 85 10 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY NUMBER OF CHANNELS 87 10.1 OVERVIEW 88 10.2 1 CHANNEL 91 10.3 2 CHANNEL 92 11 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY THERAPY 93 11.1 OVERVIEW 94 11.2 PHYSICAL THERAPY 97 11.3 OCCUPATIONAL THERAPY 98 12 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY TREATMENT 99 12.1 OVERVIEW 100 12.2 PELVIC FLOOR MUSCLE TRAINING (PFMT) 103 12.3 INTRAVAGINAL NEUROMUSCULAR ELECTRICAL STIMULATION (NMES) 104 12.4 TRANSCUTANEOUS TIBIAL NERVE STIMULATION (TTNS) 105 13 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY APPLICATION 106 13.1 OVERVIEW 107 13.2 URINARY INCONTINENCE 110 13.3 SEXUAL DYSFUNCTION 111 13.4 NEURODEGENERATIVE DISEASES 112 13.5 OTHERS 113 14 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY END USER 114 14.1 OVERVIEW 115 14.2 HOSPITALS 118 14.2.1 ACUTE CARE HOSPITALS 119 14.2.2 LONG-TERM CARE HOSPITALS 119 14.2.3 NURSING FACILITIES 119 14.2.4 REHABILITATION CENTERS 119 14.3 CLINICS 119 14.4 HOME-CARE SETTINGS 120 15 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY DISTRIBUTION CHANNEL 121 15.1 OVERVIEW 122 15.2 DIRECT TENDERS 125 15.3 THIRD PARTY DISTRIBUTION 126 15.4 OTHERS 127 16 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY GEOGRAPHY 128 16.1 OVERVIEW 129 16.2 ASIA-PACIFIC 135 16.2.1 JAPAN 143 16.2.2 CHINA 146 16.2.3 INDIA 149 16.2.4 AUSTRALIA 152 16.2.5 SOUTH KOREA 155 16.2.6 SINGAPORE 158 16.2.7 THAILAND 161 16.2.8 MALAYSIA 164 16.2.9 INDONESIA 167 16.2.10 PHILIPPINES 170 16.2.11 REST OF ASIA-PACIFIC 173 17 ASIA PACIFIC PELVIC FLOOR ELECTRIC STIMULATOR MARKET: COMPANY LANDSCAPE 174 17.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 174 18 SWOT 175 19 COMPANY PROFILES 176 19.1 LABORIE, INC. 176 19.1.1 COMPANY SNAPSHOT 176 19.1.2 COMPANY SHARE ANALYSIS 176 19.1.3 PRODUCT PORTFOLIO 177 19.1.4 RECENT DEVELOPMENTS 177 19.2 UTAH MEDICAL PRODUCTS, INC. 178 19.2.1 COMPANY SNAPSHOT 178 19.2.2 REVENUE ANALYSIS 178 19.2.3 COMPANY SHARE ANALYSIS 179 19.2.4 PRODUCT PORTFOLIO 179 19.2.5 RECENT DEVELOPMENT 179 19.3 INCONTROL MEDICAL 180 19.3.1 COMPANY SNAPSHOT 180 19.3.2 COMPANY SHARE ANALYSIS 180 19.3.3 PRODUCT PORTFOLIO 181 19.3.4 RECENT DEVELOPMENTS 181 19.4 SHENZHEN XFT MEDICAL LIMITED 182 19.4.1 COMPANY SNAPSHOT 182 19.4.2 COMPANY SHARE ANALYSIS 182 19.4.3 PRODUCT PORTFOLIO 183 19.4.4 RECENT DEVELOPMENT 183 19.5 TIC MEDIZINTECHNIK GMBH & CO. KG 184 19.5.1 COMPANY SNAPSHOT 184 19.5.2 PRODUCT PORTFOLIO 184 19.5.3 RECENT DEVELOPMENT 184 19.6 ATLANTIC THERAPEUTICS 185 19.6.1 COMPANY SNAPSHOT 185 19.6.2 PRODUCT PORTFOLIO 185 19.6.3 RECENT DEVELOPMENT 185 19.7 CLEO 186 19.7.1 COMPANY SNAPSHOT 186 19.7.2 PRODUCT PORTFOLIO 186 19.7.3 RECENT DEVELOPMENT 186 19.8 EVERYWAY MEDICAL INSTRUMENTS CO., LTD 187 19.8.1 COMPANY SNAPSHOT 187 19.8.2 PRODUCT PORTFOLIO 187 19.8.3 RECENT DEVELOPMENT 187 19.9 GYMNAUNIPHY 188 19.9.1 COMPANY SNAPSHOT 188 19.9.2 PRODUCT PORTFOLIO 188 19.9.3 RECENT DEVELOPMENTS 188 19.10 NOVUQARE 189 19.10.1 COMPANY SNAPSHOT 189 19.10.2 PRODUCT PORTFOLIO 189 19.10.3 RECENT DEVELOPMENTS 189 19.11 RELEVIUM LABS INC. 191 19.11.1 COMPANY SNAPSHOT 191 19.11.2 PRODUCT PORTFOLIO 191 19.11.3 RECENT DEVELOPMENT 191 19.12 SUGAR INTERNATIONAL 192 19.12.1 COMPANY SNAPSHOT 192 19.12.2 PRODUCT PORTFOLIO 192 19.12.3 RECENT DEVELOPMENT 192 19.13 SUNMEDIX CO, LTD. 193 19.13.1 COMPANY SNAPSHOT 193 19.13.2 PRODUCT PORTFOLIO 193 19.13.3 RECENT DEVELOPMENT 193 19.14 THE PROMETHEUS GROUP 194 19.14.1 COMPANY SNAPSHOT 194 19.14.2 PRODUCT PORTFOLIO 194 19.14.3 RECENT DEVELOPMENT 194 19.15 VERITY MEDICAL LTD 195 19.15.1 COMPANY SNAPSHOT 195 19.15.2 PRODUCT PORTFOLIO 195 19.15.3 RECENT DEVELOPMENT 195 19.16 V2U HEALTHCARE 196 19.16.1 COMPANY SNAPSHOT 196 19.16.2 PRODUCT PORTFOLIO 196 19.16.3 RECENT DEVELOPMENTS 196 20 QUESTIONNAIRE 197 21 RELATED REPORTS 200